Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

Fed’s Kashkari Says Inflation Still ‘Too High’ But Moving Right Way, Warns Of Another Tariff-Related ‘Price Bump’

by Namrata Sen | Jan 15, 2026 | General

Neel Kashkari, President of the Federal Reserve Bank of Minneapolis, voiced optimism about the U.S. economy, forecasting sustained growth and easing inflation. During a virtual town hall with the Wisconsin Bankers Association on Wednesday, Kashkari acknowledged that...

H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

by Avi Kapoor | Jan 15, 2026 | General

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares of H.B. Fuller Company (NYSE:FUL) fell sharply in pre-market trading following fourth-quarter results. H.B. Fuller reported quarterly earnings of $1.28 per...
State Street Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

State Street Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

by Avi Kapoor | Jan 15, 2026 | General

State Street Corporation (NYSE:STT) will release earnings results for the fourth quarter, before the opening bell on Friday, Jan. 16. Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $2.84 per share, up from $2.60 per share in...
Boeing To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday

Boeing To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday

by Avi Kapoor | Jan 15, 2026 | General

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays cut Nutanix Inc (NASDAQ:NTNX) price target from $64 to $53. Barclays...

EXCLUSIVE: GT Biopharma Plans 2026 Trial For New Cancer Treatment

by Vandana Singh | Jan 15, 2026 | General

GT Biopharma Inc. (NASDAQ:GTBP) on Thursday said it submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) in December 2025 for GTB-5550 TriKE for solid tumors. GTB-5550 TriKE is a B7-H3-targeted natural killer (NK) cell...

Trump’s Move On Venezuela Starves China Of A Top Construction Resource

by Stjepan Kalinic | Jan 15, 2026 | General

President Donald Trump’s intervention in Venezuela has staked the region as the U.S. sphere of influence. While the global media focused on resources like oil, Trump’s move is bigger, and it could undermine China’s ability to expand and maintain its infrastructure....
« Older Entries
Next Entries »

Recent Posts

  • Revolutionary Guard Commander Warns US: Iran ‘More Ready Than Ever, Finger on the Trigger’
  • Libya Signs 25-Year Oil Deal Worth Billions With TotalEnergies, ConocoPhillips
  • Haiti Council Moves To Oust Prime Minister, Defying US
  • Tesla China FSD Timeline Gets Pushback After Musk Davos Comments
  • Trump Threatens ‘Governor Carney’ With 100% Tariff on Canada

Recent Comments

    Archives

    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.